Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy (Q35484837)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article

Language	Label	Description	Also known as
English	Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

Hippo signaling pathway in liver and pancreas: the potential drug target for tumor therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

0 references

author name string

Delin Kong

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Yicheng Zhao

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Tong Men

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Chun-Bo Teng

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

publication date

3 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

Journal of Drug Targeting

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

125-133

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Generation and regeneration of cells of the liver and pancreas

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Elucidation of a universal size-control mechanism in Drosophila and mammals

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

YAP/TAZ as mechanosensors and mechanotransducers in regulating organ size and tumor growth

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Mutations in genes encoding the cadherin receptor-ligand pair DCHS1 and FAT4 disrupt cerebral cortical development

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

An evolutionary shift in the regulation of the Hippo pathway between mice and flies

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Mask is required for the activity of the Hippo pathway effector Yki/YAP.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Mask proteins are cofactors of Yorkie/YAP in the Hippo pathway

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The Hippo-YAP pathway: new connections between regulation of organ size and cancer

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Cell polarity in eggs and epithelia: parallels and diversity

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The roles of the cadherins Fat and Dachsous in planar polarity specification in Drosophila

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Integration of intercellular signaling through the Hippo pathway

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Interactions between the crumbs, lethal giant larvae and bazooka pathways in epithelial polarization.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

A genetic hierarchy controlling cell polarity.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Integrated activity of PDZ protein complexes regulates epithelial polarity

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

KIBRA suppresses apical exocytosis through inhibition of aPKC kinase activity in epithelial cells.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

KIBRA is a novel substrate for protein kinase Czeta

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

LIFR is a breast cancer metastasis suppressor upstream of the Hippo-YAP pathway and a prognostic marker

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Yap1 acts downstream of α-catenin to control epidermal proliferation

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

A Tight Junction-Associated Merlin-Angiomotin Complex Mediates Merlin's Regulation of Mitogenic Signaling and Tumor Suppressive Functions

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Cytoskeletal control of growth and cell fate switching

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Hippo pathway regulation by cell morphology and stress fibers.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Angiomotins link F-actin architecture to Hippo pathway signaling

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Tao kinases as coordinators of actin and microtubule dynamics in developing neurons

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Cloning of common carp SOCS-3 gene and its expression during embryogenesis, GH-transgene and viral infection

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador-Warts-Hippo pathway

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo-Salvador-Warts tumor suppressor pathway

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Cytoskeletal tension inhibits Hippo signaling through an Ajuba-Warts complex

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Role of YAP/TAZ in mechanotransduction

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

G protein-coupled receptors engage the mammalian Hippo pathway through F-actin: F-Actin, assembled in response to Galpha12/13 induced RhoA-GTP, promotes dephosphorylation and activation of the YAP oncogene

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Wnt/beta-catenin signaling: components, mechanisms, and diseases

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

YAP-induced resistance of cancer cells to antitubulin drugs is modulated by a Hippo-independent pathway.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The Hippo pathway and human cancer.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The Hippo pathway in disease and therapy: cancer and beyond

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

YAP1 increases organ size and expands undifferentiated progenitor cells

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Mst1/2 signalling to Yap: gatekeeper for liver size and tumour development

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

A cell-based assay to screen stimulators of the Hippo pathway reveals the inhibitory effect of dobutamine on the YAP-dependent gene transcription

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The hippo-yes association protein pathway in liver cancer

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The Merlin/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Nf2/Merlin controls progenitor homeostasis and tumorigenesis in the liver

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Liver stem cells: implications for hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Hippo pathway activity influences liver cell fate

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Mutual interaction between YAP and c-Myc is critical for carcinogenesis in liver cancer

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Mutual interaction between YAP and CREB promotes tumorigenesis in liver cancer

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Yes-associated protein up-regulates Jagged-1 and activates the Notch pathway in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Developmental biology of the pancreas: a comprehensive review

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Hippo signaling regulates pancreas development through inactivation of Yap.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Hippo signaling regulates differentiation and maintenance in the exocrine pancreas

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

miR-375 inhibits proliferation of mouse pancreatic progenitor cells by targeting YAP1.

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Down-regulation of Yes Associated Protein 1 expression reduces cell proliferation and clonogenicity of pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Identification, mechanism of action, and antitumor activity of a small molecule inhibitor of hippo, TGF-β, and Wnt signaling pathways

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Identification of Serum-Derived Sphingosine-1-Phosphate as a Small Molecule Regulator of YAP

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2014.983522

21 January 2018

Identifiers

10.3109/1061186X.2014.983522

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

release_4kxsno6bizbafg4bwsrqky2n7y

1 reference

https://api.fatcat.wiki/v0/release/4kxsno6bizbafg4bwsrqky2n7y

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35484837&oldid=1980705110"